Clinical Trial Update: Efficacy and Safety of Adalimumab Plus Medium Dose Oral Glucocorticosteroid for Refractory Behçet's Uveitis [Phase 4]

View source ↗

Summary

APhase 4 trial assessing the efficacy and safety of adalimumab plus medium-dose oral glucocorticosteroids for refractory Behçet's uveitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behçet Disease with Uveitis
• Uveitis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Uveitis | Phase 4 | Status: NOT_YET_RECRUITING